location： Home > Products > Signaling Pathways > New Products > New3

JNJ-54175446

Price：

Market Price：

This product is for research use only, not for human use. We do not sell to patients.

Number： - + Pieces（InventoryPieces）

InvivoChem Cat #: V4505

CAS #: 1627902-21-9Purity ≥98%

Description: JNJ-54175446 (JNJ54175446) is a novel, potent and selective brain penetrant P2X7 receptor antagonist being developed for treating major depressive disorder. It inhibits hP2X7 receptor and rP2X7 receptor with pIC50s of 8.46 and 8.81, respectively. JNJ-5417544 has suitable physicochemical properties, metabolic stability and an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing. JNJ-54175446 has been advanced as a candidate to clinical development.

References: J Med Chem. 2017 Jun 8;60(11):4559-4572

Customer Validation

Top Publications Citing Invivochem Products

详情页公告 Product Catalog 2022

Bulletin Board

详情页公告 Guide to Product Handling

Publications Citing InvivoChem Products

Physicochemical and Storage Information
Protocol
Quality Control Documentation
Related Biological Data
Customer Review

	Name: JNJ-54175446 CAS#: 1627902-21-9 Chemical Formula: C18H13ClF4N6O Exact Mass: 440.0775 Molecular Weight: 440.7866
Storage	-20℃ for 3 years in powder form
Storage	-80℃ for 2 years in solvent
Technical Information	Synonym: JNJ54175446; JNJ 54175446; JNJ-54175446 Chemical Name: (R)-(2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-4-methyl-1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridin-5-yl)methanone InChi Key: CWFVVQFVGMFTBD-SECBINFHSA-N InChi Code: InChI=1S/C18H13ClF4N6O/c1-9-15-13(29(27-26-15)17-24-7-10(20)8-25-17)5-6-28(9)16(30)11-3-2-4-12(14(11)19)18(21,22)23/h2-4,7-9H,5-6H2,1H3/t9-/m1/s1 SMILES Code: ClC1=C(C(F)(F)F)C=CC=C1C(N(CC2)[[email protected]](C)C(N=N3)=C2N3C4=NC=C(C=N4)F)=O

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
- Mass
- Concentration
- Volume
- Molecular Weight *
- =
- ×
- ×
The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂
- Concentration _(start)
- ×
- Volume _(start)
- =
- Concentration _(final)
- ×
- Volume _(final)
- ×
- =
- ×
- C1
- V1
- C2
- V2

Target	pIC50: 8.46 (hP2X7 receptor), 8.81 (rP2X7 receptor)[1]
In Vitro	JNJ-54175446 (Compound 14) is a potent and selective brain penetrant P2X7 antagonist, with pIC50s of 8.46 and 8.81 for hP2X7 and rP2X7, respectively. JNJ-54175446 shows less potent activity against mouse, dog and Macaque P2X7 (pIC50, 7.8, 7.9 and 8.1, respectively)[1].
In Vivo	JNJ-54175446 shows dose-dependent occupancy with the ED50 of 0.46 mg/kg, corresponding to plasma EC50 of 105 ng/mL[1].
References	[1].4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate.

These protocols are for reference only. InvivoChem does not independently validate these methods.

Purity ≥98%
COA
MSDS

JNJ-54175446 (JNJ54175446) is a novel, potent and selective brain penetrant P2X7 receptor antagonist being developed for treating major depressive disorder. It inhibits hP2X7 receptor and rP2X7 receptor with pIC50s of 8.46 and 8.81, respectively.

Home Prev Next Last page / pices

发评论

Your information is safe with us. * Required Fields.

Product name

Cat

Applicant name

Email address

Phone number

Organization name

Country

Requested quantity

Remarks